Cervical cancer screening for women with disabilities: Time for a new approach?

Anh Q. Nguyen, Morgan Mandigo, Jenell S. Coleman Fennell

Research output: Contribution to journalArticle

Abstract

Women with disabilities are underscreened for cervical cancer compared with the general population, likely because, in part, of both emotional and physical challenges associated with Pap testing. Women with certain disabilities often require an examination under anesthesia to undergo a speculum examination. However, anesthesia is not without risks and the perioperative experience can be burdensome to patients and caregivers. Either self-collected or provider-collected samples for human papillomavirus (HPV) testing might be better tolerated by patients, and recent evidence suggests that it is a suitable primary screening strategy. The Society of Gynecologic Oncology and the American Society for Colposcopy and Cervical Pathology published an Interim Guidance Report outlining using primary HPV testing as an option for women 25 years and older. More recently, the US Preventive Services Task Force released a recommendation statement that included the option to use oncogenic HPV testing alone for women aged 30 to 65 years. We encourage clinical researchers and professional organizations to evaluate primary HPV screening among women with disabilities to advise providers about how to best perform cervical cancer screening without the need for a speculum examination. We cannot ignore the screening disparity experienced by this population, and advocating for screening approaches that reduce patient and caregiver burden would be a step in the right direction.

Original languageEnglish (US)
Pages (from-to)318-319
Number of pages2
JournalJournal of Lower Genital Tract Disease
Volume22
Issue number4
DOIs
StatePublished - Oct 1 2018

Fingerprint

Early Detection of Cancer
Uterine Cervical Neoplasms
Surgical Instruments
Caregivers
Anesthesia
Colposcopy
Advisory Committees
Population
Research Personnel
Pathology

Keywords

  • cervical cancer screening
  • current guidelines
  • health disparity
  • primary HPV screening
  • women with disabilities

ASJC Scopus subject areas

  • Obstetrics and Gynecology

Cite this

Cervical cancer screening for women with disabilities : Time for a new approach? / Nguyen, Anh Q.; Mandigo, Morgan; Coleman Fennell, Jenell S.

In: Journal of Lower Genital Tract Disease, Vol. 22, No. 4, 01.10.2018, p. 318-319.

Research output: Contribution to journalArticle

@article{ebff5ccae6f64f2693eedd4d2d37fca9,
title = "Cervical cancer screening for women with disabilities: Time for a new approach?",
abstract = "Women with disabilities are underscreened for cervical cancer compared with the general population, likely because, in part, of both emotional and physical challenges associated with Pap testing. Women with certain disabilities often require an examination under anesthesia to undergo a speculum examination. However, anesthesia is not without risks and the perioperative experience can be burdensome to patients and caregivers. Either self-collected or provider-collected samples for human papillomavirus (HPV) testing might be better tolerated by patients, and recent evidence suggests that it is a suitable primary screening strategy. The Society of Gynecologic Oncology and the American Society for Colposcopy and Cervical Pathology published an Interim Guidance Report outlining using primary HPV testing as an option for women 25 years and older. More recently, the US Preventive Services Task Force released a recommendation statement that included the option to use oncogenic HPV testing alone for women aged 30 to 65 years. We encourage clinical researchers and professional organizations to evaluate primary HPV screening among women with disabilities to advise providers about how to best perform cervical cancer screening without the need for a speculum examination. We cannot ignore the screening disparity experienced by this population, and advocating for screening approaches that reduce patient and caregiver burden would be a step in the right direction.",
keywords = "cervical cancer screening, current guidelines, health disparity, primary HPV screening, women with disabilities",
author = "Nguyen, {Anh Q.} and Morgan Mandigo and {Coleman Fennell}, {Jenell S.}",
year = "2018",
month = "10",
day = "1",
doi = "10.1097/LGT.0000000000000432",
language = "English (US)",
volume = "22",
pages = "318--319",
journal = "Journal of Lower Genital Tract Disease",
issn = "1089-2591",
publisher = "Lippincott Williams and Wilkins",
number = "4",

}

TY - JOUR

T1 - Cervical cancer screening for women with disabilities

T2 - Time for a new approach?

AU - Nguyen, Anh Q.

AU - Mandigo, Morgan

AU - Coleman Fennell, Jenell S.

PY - 2018/10/1

Y1 - 2018/10/1

N2 - Women with disabilities are underscreened for cervical cancer compared with the general population, likely because, in part, of both emotional and physical challenges associated with Pap testing. Women with certain disabilities often require an examination under anesthesia to undergo a speculum examination. However, anesthesia is not without risks and the perioperative experience can be burdensome to patients and caregivers. Either self-collected or provider-collected samples for human papillomavirus (HPV) testing might be better tolerated by patients, and recent evidence suggests that it is a suitable primary screening strategy. The Society of Gynecologic Oncology and the American Society for Colposcopy and Cervical Pathology published an Interim Guidance Report outlining using primary HPV testing as an option for women 25 years and older. More recently, the US Preventive Services Task Force released a recommendation statement that included the option to use oncogenic HPV testing alone for women aged 30 to 65 years. We encourage clinical researchers and professional organizations to evaluate primary HPV screening among women with disabilities to advise providers about how to best perform cervical cancer screening without the need for a speculum examination. We cannot ignore the screening disparity experienced by this population, and advocating for screening approaches that reduce patient and caregiver burden would be a step in the right direction.

AB - Women with disabilities are underscreened for cervical cancer compared with the general population, likely because, in part, of both emotional and physical challenges associated with Pap testing. Women with certain disabilities often require an examination under anesthesia to undergo a speculum examination. However, anesthesia is not without risks and the perioperative experience can be burdensome to patients and caregivers. Either self-collected or provider-collected samples for human papillomavirus (HPV) testing might be better tolerated by patients, and recent evidence suggests that it is a suitable primary screening strategy. The Society of Gynecologic Oncology and the American Society for Colposcopy and Cervical Pathology published an Interim Guidance Report outlining using primary HPV testing as an option for women 25 years and older. More recently, the US Preventive Services Task Force released a recommendation statement that included the option to use oncogenic HPV testing alone for women aged 30 to 65 years. We encourage clinical researchers and professional organizations to evaluate primary HPV screening among women with disabilities to advise providers about how to best perform cervical cancer screening without the need for a speculum examination. We cannot ignore the screening disparity experienced by this population, and advocating for screening approaches that reduce patient and caregiver burden would be a step in the right direction.

KW - cervical cancer screening

KW - current guidelines

KW - health disparity

KW - primary HPV screening

KW - women with disabilities

UR - http://www.scopus.com/inward/record.url?scp=85054021780&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85054021780&partnerID=8YFLogxK

U2 - 10.1097/LGT.0000000000000432

DO - 10.1097/LGT.0000000000000432

M3 - Article

C2 - 30161053

AN - SCOPUS:85054021780

VL - 22

SP - 318

EP - 319

JO - Journal of Lower Genital Tract Disease

JF - Journal of Lower Genital Tract Disease

SN - 1089-2591

IS - 4

ER -